Concepedia

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus

M. K. Hourfar, Christine Jork, Volkmar Schottstedt, Marijke Weber‐Schehl, V. Brixner, Michael P. Busch, Geert Geusendam, Knut Gubbe, Christina Mahnhardt, U. Mayr‐Wohlfart,

Transfusion · 2008 · 190 citations · 33 references

DOI

Abstract

The risk of a blood recipient becoming infected with HCV, HIV-1, or HBV has reached an extremely low level. Introduction of individual donation testing for HCV and HIV-1 would have a marginal effect on interception of WP donations.

References

33

The Risk of Transfusion-Transmitted Viral Infections

George B. Schreiber, Michael P. Busch, Steven Kleinman et al. · New England Journal of Medicine · 1996 · 1.9K citations

Dynamics of HIV viremia and antibody seroconversion in plasma donors

Eberhard Fiebig, David J. Wright, B. D. Rawal et al. · AIDS · 2003 · 1.3K citations

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing

Susan L. Stramer, Simone A. Glynn, Steven Kleinman et al. · New England Journal of Medicine · 2004 · 539 citations · Full text

A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors

Michael P. Busch, Simone A. Glynn, Susan L. Stramer et al. · Transfusion · 2005 · 423 citations

The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations

Brian R. Jackson, M.P. Busch, Susan L. Stramer et al. · Transfusion · 2003 · 266 citations